Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Glaukos Corp (GKOS)

Glaukos Corp (GKOS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,291,652
  • Shares Outstanding, K 47,703
  • Annual Sales, $ 294,010 K
  • Annual Income, $ -49,590 K
  • 60-Month Beta 1.23
  • Price/Sales 7.97
  • Price/Cash Flow N/A
  • Price/Book 4.16
Trade GKOS with:

Options Overview Details

View History
  • Implied Volatility 44.43% ( +0.90%)
  • Historical Volatility 27.99%
  • IV Percentile 12%
  • IV Rank 14.36%
  • IV High 82.45% on 05/09/22
  • IV Low 38.06% on 11/22/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 203
  • Put/Call OI Ratio 0.37
  • Today's Open Interest 2,927
  • Open Int (30-Day) 3,931

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.56
  • Number of Estimates 7
  • High Estimate -0.44
  • Low Estimate -0.66
  • Prior Year -0.31
  • Growth Rate Est. (year over year) -80.65%

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.48 +13.65%
on 01/03/23
50.23 -3.88%
on 01/13/23
+4.60 (+10.53%)
since 12/30/22
3-Month
40.45 +19.36%
on 12/28/22
57.60 -16.18%
on 10/31/22
-9.47 (-16.40%)
since 10/28/22
52-Week
33.33 +44.85%
on 05/10/22
64.49 -25.14%
on 04/08/22
-3.31 (-6.42%)
since 01/28/22

Most Recent Stories

More News
Glaukos Announces Positive Results for iDose TR Exchange Trial, Highlighting Favorable Safety and Tolerability

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced...

GKOS : 48.28 (+0.50%)
Glaukos Announces Positive Clinical Updates for Several Corneal Health Pipeline Programs

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced...

GKOS : 48.28 (+0.50%)
Here's Why You Should Retain Glaukos (GKOS) in Your Portfolio

Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.

MMSI : 70.33 (+0.56%)
AMN : 95.47 (-0.88%)
MLAB : 189.44 (-1.98%)
GKOS : 48.28 (+0.50%)
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced...

GKOS : 48.28 (+0.50%)
3 Reasons to Retain Glaukos (GKOS) Stock in Your Portfolio

Investors continue to be optimistic about Glaukos (GKOS) on the back of continued strength in its flagship iStent.

MMSI : 70.33 (+0.56%)
EXAS : 66.21 (-1.88%)
GKOS : 48.28 (+0.50%)
SWAV : 184.35 (-1.85%)
Glaukos (GKOS) Up 0.8% Since Last Earnings Report: Can It Continue?

Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

GKOS : 48.28 (+0.50%)
TFX : 241.04 (-1.16%)
Here's Why You Should Retain Glaukos (GKOS) in Your Portfolio

Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.

MCK : 378.69 (-0.13%)
AMN : 95.47 (-0.88%)
GKOS : 48.28 (+0.50%)
LNTH : 56.27 (+0.12%)
Here's Why Glaukos (GKOS) Could be Great Choice for a Bottom Fisher

After losing some value lately, a hammer chart pattern has been formed for Glaukos (GKOS), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions,...

GKOS : 48.28 (+0.50%)
Glaukos Announces Participation in the Stephens Annual Investment Conference

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced...

GKOS : 48.28 (+0.50%)
Glaukos (GKOS) Beats on Q3 Earnings, Tightens Sales View

Glaukos' (GKOS) Q3 revenues fall year over year but beat estimates. Lower revenues along with higher expenses hurt margins.

MMSI : 70.33 (+0.56%)
GKOS : 48.28 (+0.50%)
MEDP : 214.84 (-3.95%)
ELV : 489.08 (-0.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an...

See More

Key Turning Points

3rd Resistance Point 49.63
2nd Resistance Point 48.95
1st Resistance Point 48.50
Last Price 48.28
1st Support Level 47.37
2nd Support Level 46.69
3rd Support Level 46.24

See More

52-Week High 64.49
Fibonacci 61.8% 52.59
Fibonacci 50% 48.91
Last Price 48.28
Fibonacci 38.2% 45.23
52-Week Low 33.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar